» Articles » PMID: 22484830

Quantitative Analysis of Molecular Absorption into PDMS Microfluidic Channels

Overview
Journal Ann Biomed Eng
Date 2012 Apr 10
PMID 22484830
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Microfluidic devices fabricated using poly(dimethylsiloxane) (PDMS) polymer are routinely used for in vitro cell culture for a wide range of cellular assays. These assays typically involve the incubation of cultured cells with a drug molecule or a fluorescent marker while monitoring a cellular response. The accuracy of these assays depends on achieving a consistent and reproducible concentration of solute molecules in solution. However, hydrophobic therapeutic and fluorescent molecules tend to diffuse into the PDMS walls of the microfluidic devices, which reduce their concentration in solution and consequently affect the accuracy and reliability of these assays. In this paper, we quantitatively investigate the relationship between the partition coefficient (log P) of a series of markers routinely used in in vitro cellular assays including [3H]-dexamethasone, [3H]-diazepam, [14C]-mannitol, [3H]-phenytoin, and rhodamine 6G and their absorption into PDMS microfluidic channels. Our results show that the absorption of a given solute into PDMS depends on the hydrophilic/hydrophobic balance defined by its log P value. Specifically, results demonstrate that molecules with log P less than 2.47 exhibit minimal absorption (<10%) into PDMS channels whereas molecules with log P larger than 2.62 exhibit extensive absorption (>90%) into PDMS channels. Further investigations showed that TiO(2) and glass coatings of PDMS channels reduced the absorption of hydrophobic molecules (log P > 2.62) by 2- and 4.5-folds, respectively.

Citing Articles

Modelling the maternal-fetal interface: An in vitro approach to investigate nutrient and drug transport across the human placenta.

Fuenzalida B, Basler V, Koechli N, Yi N, Staud F, Albrecht C J Cell Mol Med. 2024; 28(20):e70151.

PMID: 39422159 PMC: 11487339. DOI: 10.1111/jcmm.70151.


Targeted Cancer Therapy-on-A-Chip.

Abed H, Radha R, Anjum S, Paul V, AlSawaftah N, Pitt W Adv Healthc Mater. 2024; 13(29):e2400833.

PMID: 39101627 PMC: 11582519. DOI: 10.1002/adhm.202400833.


A Linkable, Polycarbonate Gut Microbiome-Distal Tumor Chip Platform for Interrogating Cancer Promoting Mechanisms.

Brasino D, Speese S, Schilling K, Schutt C, Barton M Adv Sci (Weinh). 2024; 11(35):e2309220.

PMID: 39023197 PMC: 11425222. DOI: 10.1002/advs.202309220.


Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy.

Mistretta M, Cimino M, Campagne P, Volant S, Kornobis E, Hebert O Nat Commun. 2024; 15(1):4175.

PMID: 38755132 PMC: 11099131. DOI: 10.1038/s41467-024-48269-2.


Reducing Cathodic Drift during Isoelectric Focusing Using Microscale Immobilized pH Gradient Gels.

Lomeli G, Herr A Anal Chem. 2024; 96(21):8648-8656.

PMID: 38716690 PMC: 11140684. DOI: 10.1021/acs.analchem.4c00788.